Segall Bryant & Hamill’s PharMerica Corporation PMC Stock Holding History

Segall Bryant & Hamill’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-268,060	Closed	-$7.85M	–	599
2017 Q3	$7.85M	Sell	268,060 -11,549	-4%	-$324K	0.18%	131
2017 Q2	$7.34M	Buy	279,609 +8,735	+3%	+$215K	0.17%	134
2017 Q1	$6.34M	Sell	270,874 -13,123	-5%	-$324K	0.15%	146
2016 Q4	$7.14M	Buy	283,997 +28,980	+11%	+$732K	0.18%	137
2016 Q3	$7.16M	Buy	+255,017	New	+$6.54M	0.18%	128

Segall Bryant & Hamill's PMC Position: Q4 2017 in Review

Segall Bryant & Hamill sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 268,060 shares — an estimated $7.85M sold.

Segall Bryant & Hamill first reported a position in PMC in Q3 2016 and held it in 5 quarters. The position peaked at $7.85M in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

Segall Bryant & Hamill reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
Segall Bryant & Hamill sold 268,060 PharMerica Corporation shares in Q4 2017, an estimated $7.85M.
Segall Bryant & Hamill first reported a position in PharMerica Corporation in Q3 2016 and held it in 5 quarters.
Segall Bryant & Hamill's PharMerica Corporation position peaked at $7.85M in Q3 2017.
0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on Segall Bryant & Hamill's 13F filing for Q4 2017, filed 15 Feb 2018.